Congress Enacts Clean Reauthorization Of FDA User Fees, Leaving Uncertain Future For Important Policy Reforms - Life Sciences, Biotechnology & Nanotechnology
On September 30, 2022, Congress passed a short-term continuing resolution ("CR"), H.R. 6833, as a temporary stopgap measure to continue funding the U.S. government past the end of the fiscal year.
Source: mondaq.com